Robert Sebastian Habib

Amministratore Delegato presso MiNA Therapeutics Ltd.

39 anni

Finance

Health Technology

Profilo

Robert Sebastian Habib has held positions as CEO and Director at MiNA Therapeutics Ltd.
and Director at Mina (Holdings) Ltd.

Società	Posizione	Inizio
Mina (Holdings) Ltd. Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014.	Direttore/Membro del Consiglio	03/11/2014
MiNA Therapeutics Ltd. MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.	Amministratore Delegato	-

Attive

Inattive

Società quotate in Borsa

Aziende private

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Aziende private	2
Mina (Holdings) Ltd. Mina (Holdings) Ltd. Financial ConglomeratesFinance Mina (Holdings) Ltd. is a holding company. The private company is based in London, UK and was founded in 2014.	Finance
MiNA Therapeutics Ltd. MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom.	Health Technology

Aziende private

Finance

Health Technology